glp-1 candidates Market Overview: Agonists and the Obesity Market | Blog GLP-1 Receptor Agonists: Who Are

The International Diabetes Federation reports there were about 589 million adults around the world living with diabetes in 2024, with 90% of these having type 2 diabetes

M., Koch, M., and Orlandi, F

Observed responses may vary depending on research amount, administration frequency, protocol duration, physiological status, inflammatory status, and individual sensitivity

This proof-of-concept study evaluated the effect of HyperSperm, a novel sperm preparation technique designed to enhance sperm function, on fertilization, embryo development, and pregnancy outcomes in both a mouse model and a first-in-human trial following IVF

doi: 10.1038/s41467-022-29972-4